Migraine with Aura: Next-Line Approach When Triptan Monotherapy Fails the 2-Hour Pain-Free Endpoint
In migraine with aura, the first-line goal is complete pain freedom two hours after treatment. When 5-HT1B/1D-agonists (triptans) are used and that endpoint is not achieved, a defined next-line protocol applies.
5-HT1B/1D-agonists (triptans) were used for moderate-to-severe attacks. Escalation to this protocol is indicated when pain-free status 2 hours after administration is not achieved.
The next step involves combining a triptan with an NSAID — a combination that outperforms either agent used alone. The specific type of NSAID selected depends on the pattern of response; the full selection guidance is in the structured protocol.
Pain-free 2 hours after administration and prevention of headache recurrence.
The initial combination of a triptan with a long-acting NSAID (such as naproxen) is more effective than the individual components and can in part prevent the recurrence of migraine attacks.
In unsatisfactory effectiveness of a triptan, the triptan may be combined with a rapid-acting NSAID.
Triptans are more effective than analgesics or NSAIDs for the endpoint 'pain-free after 2 h' in most randomized studies.
View source ↗